Type 2 diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: People in the intervention group will have 3 face-to-face 20-minute counseling sessions with the researcher on a weekly basis. In the first session, anthropometry,
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Refer to Imam khomeini educational-therapeutic center and Tadbir clinic in Urmia city Having T2DM based on a physician's diagnosis and FPG criteria equal to and greater than 126 mg/dL and HbA1C equal to and greater than 6.5% Age above 18 years No insulin injection
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Gastroparesis Following a special diet Consumption of nutritional supplements in the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Fasting blood sugar measurement at the beginning of the study (before the start of the intervention) and 16 week of the study (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Enzymatic method - international unit per liter.;Glycosylated hemoglobin A1c. Timepoint: Measurement of glycosylated hemoglobin A1c at the beginning of the study (before the start of the intervention) and week 16 of the study (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Enzymatic method - milligrams per deciliter.;Waist circumference. Timepoint: Measurement of waist circumference at the beginning of the study (before the start of the intervention) and week 16 of the study (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Tape meters-centimeters.;Systolic blood pressure. Timepoint: Measurement of systolic blood pressure at the beginning of the study (before the start of the intervention) and week 16 of the study (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Digital sphygmomanometer - millimeters of mercury(mmHg).;Diastolic blood pressure. Timepoint: Measurement of diastolic blood pressure at the beginning of the study (before the start of the intervention) and week 16 of the study (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Digital sphygmomanometer - millimeters of mercury(mmHg).;Triglyceride. Timepoint: Measurement of triglyceride at the beginning of the study (before the start of the intervention) and week 16 of the study (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Enzymatic method - milligrams per deciliter.;LDL-cholesterol. Timepoint: Measurement of LDL-cholesterol at the beginning of the study (before the start of the intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: Total cholesterol measurement at the beginning of the study (before the start of the intervention) and week 16 (12 weeks after. Method of measurement: Enzymatic method - milligrams per deciliter.;Body mass index. Timepoint: Body mass index measurement at the beginning of the study (before the start of the intervention) and week 16 (12 weeks after. Method of measurement: Weight/ height squared.;Weight. Timepoint: Weight measurement at the beginning of the study (before the start of the intervention) and week 16 (12 weeks after the end of the counseling sessions of the intervention group). Method of measurement: Scale-kilogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Alizadeh
Oroumia University of Medical Sciences
Outcome results
None listed